A Multicenter Study Evaluating Efficacy and Safety of 177Lu-DOTA-TATE Based on Kidney-Dosimetry in Patients With Disseminated Neuroendocrine Tumors

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
By improved kidney dosimetry including biological effective dose and taking into account potential risk factors (especially for kidney toxicity), it might be possible to give an optimal and personalized treatment with 177Lu-DOTA-TATE to the patient with metastatic neuroendocrine tumor.
Epistemonikos ID: 15c7542660bdfa7040cb4e2dc9f17db7cbe426bc
First added on: May 10, 2024